Charles W. Newton, Chief Financial Officer at Lyell Immunopharma, Inc. (LYEL), bought 400,000 shares at $0.56 ($224K) on 2025-03-17, disclosed to the SEC on 2025-03-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.56 | 200,000 | $112K | 50.0% |
| 2 | $0.56 | 200,000 | $112K | 50.0% |
| Total | $0.56 avg | 400,000 | $224K | 100% |
| Filing → |
| LYEL | SELL | 2025-08-22 | $15K | — | Filing → |
| LYEL | SELL | 2025-08-13 | $3K | — | Filing → |